• Decision to Expand Facilities of AGC Pharma Chemicals Europe

• Decision to Expand Facilities at AGC Wakasa Chemical’s Kamiji Plant

• Decision to Expand Facilities at AGC Pharma Chemicals Europe

• Acquisition of a Synthetic Pharmaceutical API Manufacturing Facility in Spain (Currently AGC Pharma Chemicals…

• AGC Wakasa Chemical Establishes Kamiji Plant in Wakasa Techno Valley

• Approval for Manufacturing and Marketing of the Glaucoma Treatment API “Tafluprost”

• Completion of Full-Scale GMP-Compliant Multipurpose Clinical Trial Drug Manufacturing Facility at Chiba Plant

• Establishment of Wakasa AGC Fine Chemical (currently AGC Wakasa Chemical)

• Contract Manufacturing/Supply of Fluorinated Intermediates for Antibacterial Agents to Pharmaceutical Companies

• AGC founded in Japan